Our CEO, Nick, discussed our journey to repurpose nitisinone to treat AKU at LifeArc's #LATSS2024 conference🔬

Our global AKU patient registry has launched🎉

'With so few AKU patients spread across the globe, a coordinated international registry is crucial for amassing sufficient data to support clinical research' - Professor Ranganath

Find out more here🔗
👉buff.ly/43LJWY9

Our latest blog discusses the launch of our global AKU patient registry🌏

Read more here👇
buff.ly/3Q4lg7w

AKU Society launches Global Patient Registry to drive research into ultra-rare disease #Alkaptonuria .

Read at bit.ly/4aR9NQX

#PressRelease AKU Society

A huge achievement.

Well done to our member organisation, AKU Society for launching the first-ever global patient registry for #alkaptonuria , an ultra-rare inherited #metabolic disorder.

We are recruiting for a #PhD position at University of Liverpool🔬

'Study of early pathological changes in calcified cartilage in osteoarthritis and alkaptonuria'
👉buff.ly/3PSLtpM

#PhD Careers #Scholarship #Research #RareDisease #PhD Opportunity #MetabolicDisorder

We are recruiting for a #PhD position at University of Liverpool🔬

'Study of early pathological changes in calcified cartilage in osteoarthritis and alkaptonuria'
👉buff.ly/3PSLtpM

#PhD Careers #Scholarship #Research #RareDisease #PhD Opportunity #MetabolicDisorder

I have an exciting, fully funded #PhD position in my lab in Institute of Life Course and Medical Sciences. Co-supervised by Prof George Bou-Gharios and Prof Andrew Pitsillides

Deadline: 10th May 24.

Co-funded by University of Liverpool and AKU Society

#osteoarthrtis #AKU #cartilage #pigmentation

tinyurl.com/mprvjmup

Our global AKU patient registry has launched🌏

The registry will allow us to track the prevalence and progression of AKU around the world, helping us to drive our research forward and work towards universal access to nitisinone treatment🔬

Join here 👉buff.ly/43LJWY9

Our global AKU patient registry has launched🌏

The registry will allow us to track the prevalence and progression of AKU around the world, helping us to drive our research forward and work towards universal access to nitisinone treatment🔬

Join here 👉buff.ly/43LJWY9

The Q&A panel on stage Rare Disease Research UK
#rdrukcon
#RareDisease #Research conference

NIHR Research
NIHR Involvement

cc AKU Society

New primer highlights latest understanding of rare inherited disease #Alkaptonuria .

Read at bit.ly/43pecI8

#PressRelease

There are many people affected by #raredisease & #disabilities who are struggling with the #costoflivingcrisis , which is why, working alongside partners such as the AKU Society we’ve created a brand new info resource to help you at this challenging time:

samebutdifferentcic.org.uk/costofliving

Two #PhD positions researching #AKU at University of Liverpool 🚨

#PhD Careers #Scholarship #Research #RareDisease #OxidativeStress #PhD Opportunity #MetabolicDisorder

Why don’t mice models of alkaptonuria exhibit the same levels of #ochronosis seen in humans?

New insights from Norman et al in The Journal of Inherited Metabolic Disease may reveal the answer👇
buff.ly/49ONriN

Why don’t mice models of alkaptonuria exhibit the same levels of #ochronosis seen in humans?

New insights from Norman et al in The Journal of Inherited Metabolic Disease may reveal the answer👇
buff.ly/49ONriN

Why don’t mice models of alkaptonuria exhibit the same levels of ochronosis seen in humans? New insights from Norman et al may reveal the answer.

doi.org/10.1002/jimd.1…
AKU Society Anna Milan Dr Juliette Hughes #alkaptonuria #AKU

Two #PhD positions researching #AKU at University of Liverpool 🚨

#PhD Careers #Scholarship #Research #RareDisease #OxidativeStress #PhD Opportunity #MetabolicDisorder

We are recruiting for two #PhD positions at University of Liverpool 🔬

‘Exploring tyrosine metabolism as a source of oxidative stress’
👉buff.ly/3VwXkgX

‘Investigating the role of oxidative metabolites in joint destruction in osteoarthritis’
👉buff.ly/3wYgy4t

📰Following his talk at @REMEDi4AL's #iDR24 conference, our CEO Nick spoke to
EL PAÍS about the power of drug repurposing💊

Read more here👇
buff.ly/49Nk0gV